These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7732817)

  • 41. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A simple method for estimation of lipoxygenase and cyclo-oxygenase pathways in human platelets--the use of thiobarbituric acid reaction.
    Takayama H; Okuma M; Uchino H
    Thromb Haemost; 1980 Dec; 44(3):111-4. PubMed ID: 6781093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 45. Reversible acylation and inhibition of aggregation of platelets by substituted maleic anhydrides.
    Walder JA; Hyman BT; Heller MJ; Shishido RY; Klotz IM
    Mol Pharmacol; 1977 May; 13(3):407-14. PubMed ID: 406514
    [No Abstract]   [Full Text] [Related]  

  • 46. Towards a better aspirin.
    Vane J
    Nature; 1994 Jan; 367(6460):215-6. PubMed ID: 8121485
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from "in vivo" drug interaction studies in rats.
    Cerletti C; Livio M; De Gaetano G
    Biochim Biophys Acta; 1982 Jan; 714(1):122-8. PubMed ID: 6799004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages.
    Dieter P; Scheibe R; Jakobsson PJ; Watanabe K; Kolada A; Kamionka S
    Biochem Biophys Res Commun; 2000 Sep; 276(2):488-92. PubMed ID: 11027502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin synthase inhibitory activity in plasma of women with dysmenorrhea.
    Strickland DM; Cox K; Saeed SA; Mitchell MD
    J Reprod Med; 1984 May; 29(5):331-3. PubMed ID: 6427460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do human platelets express COX-2?
    Reiter R; Resch U; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):299-305. PubMed ID: 11427038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inactivation of prostaglandin endoperoxide synthetase from the microsomal fraction of human platelets during the reaction].
    Mevkh AT; Basevich VV; Iarving I; Varfolomeev SD
    Biokhimiia; 1982 Nov; 47(11):1852-8. PubMed ID: 6817828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material.
    Violi F; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Lipids; 1985 May; 20(5):322-4. PubMed ID: 3925272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin In The Prevention Of Pre-Eclampsia: Where Are We Now?
    Khalid A; Byrne BM
    Ir Med J; 2018 Mar; 111(3):704. PubMed ID: 30376222
    [No Abstract]   [Full Text] [Related]  

  • 56. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated extraction and HPLC resolution of lipoxygenase and cyclooxygenase products utilizing high pressure column switching.
    Pickett WC; Douglas MB
    Prostaglandins; 1985 Jan; 29(1):83-90. PubMed ID: 3919424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thromboxane-B(2) levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion.
    Thomson M; Mustafa T; Ali M
    Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):217-21. PubMed ID: 11049697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Platelet cyclooxygenase deficiency].
    Fuse I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):369-71. PubMed ID: 9833516
    [No Abstract]   [Full Text] [Related]  

  • 60. Enzymological and immunological studies on a clinical case of platelet cyclooxygenase abnormality.
    Ehara H; Yoshimoto T; Yamamoto S; Hattori A
    Biochim Biophys Acta; 1988 May; 960(1):35-42. PubMed ID: 2451934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.